Published in Cell Growth Differ on July 01, 1994
Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16
20 years studying p53 functions in genetically engineered mice. Nat Rev Cancer (2009) 2.00
Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am J Pathol (2006) 1.80
Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest (1996) 1.33
neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol Cell Biol (1997) 1.27
Choosing a mouse model: experimental biology in context--the utility and limitations of mouse models of breast cancer. Cold Spring Harb Perspect Biol (2011) 1.03
Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer? Breast Cancer Res (2002) 0.88
Epigenetic modifications unlock the milk protein gene loci during mouse mammary gland development and differentiation. PLoS One (2013) 0.86
Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer. Front Oncol (2015) 0.79
Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16
An interactive graphics-based model of the lower extremity to study orthopaedic surgical procedures. IEEE Trans Biomed Eng (1990) 5.65
Metastatic prostate cancer in a transgenic mouse. Cancer Res (1996) 4.02
Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression. Cell (1979) 3.78
Application of high-tech three-dimensional imaging and computer-generated models in complex facial reconstructions with vascularized bone grafts. Plast Reconstr Surg (1993) 2.77
A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model. FASEB J (2000) 2.73
bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res (1995) 2.56
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med (1996) 2.51
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci U S A (2001) 2.50
Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys (1995) 2.50
Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci U S A (1984) 2.44
Preparation and preliminary characterization of purified ovalbumin messenger RNA from the hen oviduct. Biochemistry (1975) 2.42
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev (1995) 2.41
Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development (1996) 2.35
Physical and chemical characterization of purified ovalbumin messenger RNA. J Biol Chem (1975) 2.28
C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev (1998) 2.27
The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol (1994) 2.22
C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol (2000) 2.11
Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol (2001) 2.05
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene (2000) 2.03
Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res (2001) 1.91
A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J Cell Sci (1988) 1.90
Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res (1999) 1.87
Overlapping sites for constitutive and induced DNA binding factors involved in interferon-stimulated transcription. EMBO J (1989) 1.87
Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome. Am J Pathol (2000) 1.84
Comparison of the whey acidic protein genes of the rat and mouse. Nucleic Acids Res (1984) 1.81
Complex hormonal regulation of rat casein gene expression. J Biol Chem (1982) 1.80
Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology (1996) 1.74
Use of a specific probe for ovalbumin messenger RNA to quantitate estrogen-induced gene transcripts. Biochemistry (1975) 1.69
Early events in the import/assembly pathway of an integral thylakoid protein. Eur J Biochem (1990) 1.68
Regulation of casein messenger RNA during the development of the rat mammary gland. Biochemistry (1975) 1.66
Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene (1999) 1.60
Effects of continuous hyperfractionated accelerated and conventionally fractionated radiotherapy on the parotid and submandibular salivary glands of rhesus monkeys. Radiother Oncol (1995) 1.58
PAK1 hyperactivation is sufficient for mammary gland tumor formation. Oncogene (2006) 1.57
Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog (1996) 1.56
Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene (1995) 1.55
Frozen human serum reference material for standardization of sodium and potassium measurements in serum or plasma by ion-selective electrode analyzers. Clin Chem (1992) 1.55
Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res (1998) 1.51
Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol Endocrinol (1997) 1.50
Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro. Cancer Res (1992) 1.49
Isolation and characterization of functional mammary gland stem cells. Cell Prolif (2003) 1.49
Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J Natl Cancer Inst (1997) 1.47
Distinction between the preneoplastic and neoplastic state of murine mammary glands. Proc Natl Acad Sci U S A (1972) 1.47
The rat casein multigene family. I. Fine structure of the gamma-casein gene. J Biol Chem (1983) 1.45
Acute eosinophilic pneumonia associated with shock. Crit Care Med (1999) 1.45
Rat beta casein cDNA: sequence analysis and evolutionary comparisons. Nucleic Acids Res (1982) 1.44
Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol (1983) 1.43
[Septic shock (I). Physiopathology, monitoring]. Med Clin (Barc) (1993) 1.41
The influence of host and tissue age on life span and growth rate of serially transplanted mouse mammary gland. Exp Gerontol (1971) 1.41
Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell (2001) 1.40
A pilot study of an enhanced mental health assessment during routine and discharge medicals in the British Armed Forces. J R Army Med Corps (2013) 1.39
Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys (1996) 1.38
Nuclear factor I and mammary gland factor (STAT5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice. Mol Cell Biol (1995) 1.37
Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development. Mol Endocrinol (1994) 1.36
p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci U S A (2001) 1.35
Comparative sequence analysis of the mRNAs coding for mouse and rat whey protein. Nucleic Acids Res (1982) 1.35
Adenovirus-Cre-mediated recombination in mammary epithelial early progenitor cells. J Cell Sci (2001) 1.34
Localization of the casein gene family to a single mouse chromosome. J Cell Biol (1982) 1.33
Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression. Mol Endocrinol (1995) 1.32
Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis (1998) 1.31
The rat casein multigene family. Fine structure and evolution of the beta-casein gene. J Biol Chem (1985) 1.30
Evaluation of a fiber optic glove for semi-automated goniometric measurements. J Rehabil Res Dev (1990) 1.29
Evolution of the casein multigene family: conserved sequences in the 5' flanking and exon regions. Nucleic Acids Res (1986) 1.28
Risk factors for post-traumatic stress disorder among UK Armed Forces personnel. Psychol Med (2008) 1.28
Prolactin induction of casein mRNA in organ culture. A model system for studying peptide hormone regulation of gene expression. J Biol Chem (1978) 1.27
Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thioether, diallyl sulfide. Cancer Res (1988) 1.27
Preferential growth of mammary tumors in intact mammary fatpads. Cancer Res (1981) 1.27
neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol Cell Biol (1997) 1.27
The influence of mammogenic hormones on serially transplanted mouse mammary gland. Exp Gerontol (1971) 1.26
Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo. Endocrinology (1997) 1.26
Measurement of mRNA concentration and mRNA half-life as a function of hormonal treatment. Methods Enzymol (1985) 1.25
Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol (1995) 1.24
Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res (2001) 1.22
A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res (2001) 1.21
Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science (1977) 1.21
Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol (2001) 1.21
Both cell substratum regulation and hormonal regulation of milk protein gene expression are exerted primarily at the posttranscriptional level. Mol Cell Biol (1988) 1.20
Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys (2001) 1.20
The mammary fat pad. J Mammary Gland Biol Neoplasia (1998) 1.19
Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol Endocrinol (1999) 1.18
Construction and preliminary characterization of the rat casein and alpha-lactalbumin cDNA clones. J Biol Chem (1981) 1.18
Expression of pregnancy-specific genes in preneoplastic mouse mammary tissues from virgin mice. Cancer Res (1984) 1.17
Heterozygosity of p21WAF1/CIP1 enhances tumor cell proliferation and cyclin D1-associated kinase activity in a murine mammary cancer model. Cell Growth Differ (1999) 1.16
Acute and late radiation injury in rhesus monkey parotid glands. Evidence of interphase cell death. Am J Pathol (1986) 1.16
Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis. Oncogene (1998) 1.16
Tissue-specific expression of the rat beta-casein gene in transgenic mice. Nucleic Acids Res (1988) 1.16
Progesterone-mediated inhibition of casein mRNA and polysomal casein synthesis in the rat mammary gland during pregnancy. Biochemistry (1978) 1.16
Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB-c and C57BL mice. J Natl Cancer Inst (1974) 1.16
Localization and quantification of Wnt-2 gene expression in mouse mammary development. Dev Biol (1993) 1.16
A school-based measles outbreak: the effect of a selective revaccination policy and risk factors for vaccine failure. Am J Epidemiol (1990) 1.14
Mammary tumorigenesis in 7,12-dimethybenzanthracene-treated C57BL x DBA/2f F1 mice. Cancer Res (1980) 1.14
Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis. Antimicrob Agents Chemother (1994) 1.13
Isolation and characterization of purified rat casein messenger ribonucleic acids. Biochemistry (1976) 1.13
Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor. Mol Endocrinol (2001) 1.13
L-asparaginase kills lymphoma cells by apoptosis. Cancer Chemother Pharmacol (1993) 1.12